aluates Reports

$ 0.0

Automative

Global Viral Vector Purification Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-29B11713

Global Viral Vector Purification Market Research Report 2022

BUY CHAPTERS

Global Viral Vector Purification Market Research Report 2025

Code: QYRE-Auto-29B11713

Report

March 2025

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Creative-Biolabs

Bio-Rad Laboratories Inc

Sirion-Biotech GmbH

Merck KGaA

FUJIFILM Diosynth Biotechnologies

ProBioGen

Applied Biological Materials Inc

Batavia Biosciences B.V.

Agilent Technologies Inc

Addgene

IDT Biologika GmbH

Takara Bio Inc

Thermo Fisher Scientific Inc

Waisman Biomanufacturing

Creative Biogene

Aldevron

BioVision

Viral Vector Purification Market Size

The global market for Viral Vector Purification was valued at US$ 8178 million in the year 2024 and is projected to reach a revised size of US$ 19250 million by 2031, growing at a CAGR of 13.2% during the forecast period.

Viral Vector Purification Market

Viral vector purification is a critical step in the production of gene therapy and vaccine products that utilize viral vectors. Viral vectors are vehicles used to deliver genetic material (e.g., therapeutic genes, antigens) into target cells for various applications, including gene therapy and vaccination. The purification process is necessary to isolate and concentrate the viral vectors while removing impurities and contaminants. The goal is to produce a highly purified and potent viral vector product for safe and effective use in patients.

There is a trend toward the development of automated purification processes that can handle larger volumes and improve overall efficiency. High-throughput purification methods can be crucial for meeting the increasing demand for viral vectors in clinical and commercial applications.

This report aims to provide a comprehensive presentation of the global market for Viral Vector Purification, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Purification.

The Viral Vector Purification market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Viral Vector Purification market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Viral Vector Purification companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Viral Vector Purification Market Report

Report Metric	Details
Report Name	Viral Vector Purification Market
Accounted market size in year	US$ 8178 million
Forecasted market size in 2031	US$ 19250 million
CAGR	13.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	In Vivo In Vitro
Segment by Application	Gene Therapy Cell Therapy Vaccinology
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Applied Biological Materials Inc., Creative Biolabs, Bio-Rad Laboratories, Inc., Sirion-Biotech GmbH, Merck KGaA, FUJIFILM Diosynth Biotechnologies, Batavia Biosciences B.V., Agilent Technologies, Inc., Addgene, IDT Biologika GmbH, ProBioGen AG, Takara Bio Inc., Thermo Fisher Scientific Inc.,, Waisman Biomanufacturing, Creative Biogene, Aldevron, BioVision Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vector Purification company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Viral Vector Purification Market growing?

Ans: The Viral Vector Purification Market witnessing a CAGR of 13.2% during the forecast period 2025-2031.

What is the Viral Vector Purification Market size in 2031?

Ans: The Viral Vector Purification Market size in 2031 will be US$ 19250 million.

Who are the main players in the Viral Vector Purification Market report?

Ans: The main players in the Viral Vector Purification Market are Applied Biological Materials Inc., Creative Biolabs, Bio-Rad Laboratories, Inc., Sirion-Biotech GmbH, Merck KGaA, FUJIFILM Diosynth Biotechnologies, Batavia Biosciences B.V., Agilent Technologies, Inc., Addgene, IDT Biologika GmbH, ProBioGen AG, Takara Bio Inc., Thermo Fisher Scientific Inc.,, Waisman Biomanufacturing, Creative Biogene, Aldevron, BioVision Inc.

What are the Application segmentation covered in the Viral Vector Purification Market report?

Ans: The Applications covered in the Viral Vector Purification Market report are Gene Therapy, Cell Therapy, Vaccinology

What are the Type segmentation covered in the Viral Vector Purification Market report?

Ans: The Types covered in the Viral Vector Purification Market report are In Vivo, In Vitro

Recommended Reports

Gene Therapy Solutions

Viral Vector Purification

Nucleic Acid Purification

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Viral Vector Purification Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 In Vivo

1.2.3 In Vitro

1.3 Market by Application

1.3.1 Global Viral Vector Purification Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Gene Therapy

1.3.3 Cell Therapy

1.3.4 Vaccinology

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Viral Vector Purification Market Perspective (2020-2031)

2.2 Global Viral Vector Purification Growth Trends by Region

2.2.1 Global Viral Vector Purification Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Viral Vector Purification Historic Market Size by Region (2020-2025)

2.2.3 Viral Vector Purification Forecasted Market Size by Region (2026-2031)

2.3 Viral Vector Purification Market Dynamics

2.3.1 Viral Vector Purification Industry Trends

2.3.2 Viral Vector Purification Market Drivers

2.3.3 Viral Vector Purification Market Challenges

2.3.4 Viral Vector Purification Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Viral Vector Purification Players by Revenue

3.1.1 Global Top Viral Vector Purification Players by Revenue (2020-2025)

3.1.2 Global Viral Vector Purification Revenue Market Share by Players (2020-2025)

3.2 Global Viral Vector Purification Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Viral Vector Purification Revenue

3.4 Global Viral Vector Purification Market Concentration Ratio

3.4.1 Global Viral Vector Purification Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Purification Revenue in 2024

3.5 Global Key Players of Viral Vector Purification Head office and Area Served

3.6 Global Key Players of Viral Vector Purification, Product and Application

3.7 Global Key Players of Viral Vector Purification, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Vector Purification Breakdown Data by Type

4.1 Global Viral Vector Purification Historic Market Size by Type (2020-2025)

4.2 Global Viral Vector Purification Forecasted Market Size by Type (2026-2031)

5 Viral Vector Purification Breakdown Data by Application

5.1 Global Viral Vector Purification Historic Market Size by Application (2020-2025)

5.2 Global Viral Vector Purification Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Viral Vector Purification Market Size (2020-2031)

6.2 North America Viral Vector Purification Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Viral Vector Purification Market Size by Country (2020-2025)

6.4 North America Viral Vector Purification Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Viral Vector Purification Market Size (2020-2031)

7.2 Europe Viral Vector Purification Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Viral Vector Purification Market Size by Country (2020-2025)

7.4 Europe Viral Vector Purification Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Viral Vector Purification Market Size (2020-2031)

8.2 Asia-Pacific Viral Vector Purification Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Viral Vector Purification Market Size by Region (2020-2025)

8.4 Asia-Pacific Viral Vector Purification Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Viral Vector Purification Market Size (2020-2031)

9.2 Latin America Viral Vector Purification Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Viral Vector Purification Market Size by Country (2020-2025)

9.4 Latin America Viral Vector Purification Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Viral Vector Purification Market Size (2020-2031)

10.2 Middle East & Africa Viral Vector Purification Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Viral Vector Purification Market Size by Country (2020-2025)

10.4 Middle East & Africa Viral Vector Purification Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Applied Biological Materials Inc.

11.1.1 Applied Biological Materials Inc. Company Details

11.1.2 Applied Biological Materials Inc. Business Overview

11.1.3 Applied Biological Materials Inc. Viral Vector Purification Introduction

11.1.4 Applied Biological Materials Inc. Revenue in Viral Vector Purification Business (2020-2025)

11.1.5 Applied Biological Materials Inc. Recent Development

11.2 Creative Biolabs

11.2.1 Creative Biolabs Company Details

11.2.2 Creative Biolabs Business Overview

11.2.3 Creative Biolabs Viral Vector Purification Introduction

11.2.4 Creative Biolabs Revenue in Viral Vector Purification Business (2020-2025)

11.2.5 Creative Biolabs Recent Development

11.3 Bio-Rad Laboratories, Inc.

11.3.1 Bio-Rad Laboratories, Inc. Company Details

11.3.2 Bio-Rad Laboratories, Inc. Business Overview

11.3.3 Bio-Rad Laboratories, Inc. Viral Vector Purification Introduction

11.3.4 Bio-Rad Laboratories, Inc. Revenue in Viral Vector Purification Business (2020-2025)

11.3.5 Bio-Rad Laboratories, Inc. Recent Development

11.4 Sirion-Biotech GmbH

11.4.1 Sirion-Biotech GmbH Company Details

11.4.2 Sirion-Biotech GmbH Business Overview

11.4.3 Sirion-Biotech GmbH Viral Vector Purification Introduction

11.4.4 Sirion-Biotech GmbH Revenue in Viral Vector Purification Business (2020-2025)

11.4.5 Sirion-Biotech GmbH Recent Development

11.5 Merck KGaA

11.5.1 Merck KGaA Company Details

11.5.2 Merck KGaA Business Overview

11.5.3 Merck KGaA Viral Vector Purification Introduction

11.5.4 Merck KGaA Revenue in Viral Vector Purification Business (2020-2025)

11.5.5 Merck KGaA Recent Development

11.6 FUJIFILM Diosynth Biotechnologies

11.6.1 FUJIFILM Diosynth Biotechnologies Company Details

11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.6.3 FUJIFILM Diosynth Biotechnologies Viral Vector Purification Introduction

11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Purification Business (2020-2025)

11.6.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.7 Batavia Biosciences B.V.

11.7.1 Batavia Biosciences B.V. Company Details

11.7.2 Batavia Biosciences B.V. Business Overview

11.7.3 Batavia Biosciences B.V. Viral Vector Purification Introduction

11.7.4 Batavia Biosciences B.V. Revenue in Viral Vector Purification Business (2020-2025)

11.7.5 Batavia Biosciences B.V. Recent Development

11.8 Agilent Technologies, Inc.

11.8.1 Agilent Technologies, Inc. Company Details

11.8.2 Agilent Technologies, Inc. Business Overview

11.8.3 Agilent Technologies, Inc. Viral Vector Purification Introduction

11.8.4 Agilent Technologies, Inc. Revenue in Viral Vector Purification Business (2020-2025)

11.8.5 Agilent Technologies, Inc. Recent Development

11.9 Addgene

11.9.1 Addgene Company Details

11.9.2 Addgene Business Overview

11.9.3 Addgene Viral Vector Purification Introduction

11.9.4 Addgene Revenue in Viral Vector Purification Business (2020-2025)

11.9.5 Addgene Recent Development

11.10 IDT Biologika GmbH

11.10.1 IDT Biologika GmbH Company Details

11.10.2 IDT Biologika GmbH Business Overview

11.10.3 IDT Biologika GmbH Viral Vector Purification Introduction

11.10.4 IDT Biologika GmbH Revenue in Viral Vector Purification Business (2020-2025)

11.10.5 IDT Biologika GmbH Recent Development

11.11 ProBioGen AG

11.11.1 ProBioGen AG Company Details

11.11.2 ProBioGen AG Business Overview

11.11.3 ProBioGen AG Viral Vector Purification Introduction

11.11.4 ProBioGen AG Revenue in Viral Vector Purification Business (2020-2025)

11.11.5 ProBioGen AG Recent Development

11.12 Takara Bio Inc.

11.12.1 Takara Bio Inc. Company Details

11.12.2 Takara Bio Inc. Business Overview

11.12.3 Takara Bio Inc. Viral Vector Purification Introduction

11.12.4 Takara Bio Inc. Revenue in Viral Vector Purification Business (2020-2025)

11.12.5 Takara Bio Inc. Recent Development

11.13 Thermo Fisher Scientific Inc.,

11.13.1 Thermo Fisher Scientific Inc., Company Details

11.13.2 Thermo Fisher Scientific Inc., Business Overview

11.13.3 Thermo Fisher Scientific Inc., Viral Vector Purification Introduction

11.13.4 Thermo Fisher Scientific Inc., Revenue in Viral Vector Purification Business (2020-2025)

11.13.5 Thermo Fisher Scientific Inc., Recent Development

11.14 Waisman Biomanufacturing

11.14.1 Waisman Biomanufacturing Company Details

11.14.2 Waisman Biomanufacturing Business Overview

11.14.3 Waisman Biomanufacturing Viral Vector Purification Introduction

11.14.4 Waisman Biomanufacturing Revenue in Viral Vector Purification Business (2020-2025)

11.14.5 Waisman Biomanufacturing Recent Development

11.15 Creative Biogene

11.15.1 Creative Biogene Company Details

11.15.2 Creative Biogene Business Overview

11.15.3 Creative Biogene Viral Vector Purification Introduction

11.15.4 Creative Biogene Revenue in Viral Vector Purification Business (2020-2025)

11.15.5 Creative Biogene Recent Development

11.16 Aldevron

11.16.1 Aldevron Company Details

11.16.2 Aldevron Business Overview

11.16.3 Aldevron Viral Vector Purification Introduction

11.16.4 Aldevron Revenue in Viral Vector Purification Business (2020-2025)

11.16.5 Aldevron Recent Development

11.17 BioVision Inc.

11.17.1 BioVision Inc. Company Details

11.17.2 BioVision Inc. Business Overview

11.17.3 BioVision Inc. Viral Vector Purification Introduction

11.17.4 BioVision Inc. Revenue in Viral Vector Purification Business (2020-2025)

11.17.5 BioVision Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Creative-Biolabs

Bio-Rad Laboratories Inc

Sirion-Biotech GmbH

Merck KGaA

FUJIFILM Diosynth Biotechnologies

ProBioGen

Applied Biological Materials Inc

Batavia Biosciences B.V.

Agilent Technologies Inc

Addgene

IDT Biologika GmbH

Takara Bio Inc

Thermo Fisher Scientific Inc

Waisman Biomanufacturing

Creative Biogene

Aldevron

BioVision

List of Tables

Table 1. Global Viral Vector Purification Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of In Vivo

Table 3. Key Players of In Vitro

Table 4. Global Viral Vector Purification Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Viral Vector Purification Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Viral Vector Purification Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Viral Vector Purification Market Share by Region (2020-2025)

Table 8. Global Viral Vector Purification Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Viral Vector Purification Market Share by Region (2026-2031)

Table 10. Viral Vector Purification Market Trends

Table 11. Viral Vector Purification Market Drivers

Table 12. Viral Vector Purification Market Challenges

Table 13. Viral Vector Purification Market Restraints

Table 14. Global Viral Vector Purification Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Viral Vector Purification Market Share by Players (2020-2025)

Table 16. Global Top Viral Vector Purification Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Purification as of 2024)

Table 17. Ranking of Global Top Viral Vector Purification Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Viral Vector Purification Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Viral Vector Purification, Headquarters and Area Served

Table 20. Global Key Players of Viral Vector Purification, Product and Application

Table 21. Global Key Players of Viral Vector Purification, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Viral Vector Purification Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Viral Vector Purification Revenue Market Share by Type (2020-2025)

Table 25. Global Viral Vector Purification Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Viral Vector Purification Revenue Market Share by Type (2026-2031)

Table 27. Global Viral Vector Purification Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Viral Vector Purification Revenue Market Share by Application (2020-2025)

Table 29. Global Viral Vector Purification Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Viral Vector Purification Revenue Market Share by Application (2026-2031)

Table 31. North America Viral Vector Purification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Viral Vector Purification Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Viral Vector Purification Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Viral Vector Purification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Viral Vector Purification Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Viral Vector Purification Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Viral Vector Purification Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Viral Vector Purification Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Viral Vector Purification Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Viral Vector Purification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Viral Vector Purification Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Viral Vector Purification Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Viral Vector Purification Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Viral Vector Purification Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Viral Vector Purification Market Size by Country (2026-2031) & (US$ Million)

Table 46. Applied Biological Materials Inc. Company Details

Table 47. Applied Biological Materials Inc. Business Overview

Table 48. Applied Biological Materials Inc. Viral Vector Purification Product

Table 49. Applied Biological Materials Inc. Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 50. Applied Biological Materials Inc. Recent Development

Table 51. Creative Biolabs Company Details

Table 52. Creative Biolabs Business Overview

Table 53. Creative Biolabs Viral Vector Purification Product

Table 54. Creative Biolabs Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 55. Creative Biolabs Recent Development

Table 56. Bio-Rad Laboratories, Inc. Company Details

Table 57. Bio-Rad Laboratories, Inc. Business Overview

Table 58. Bio-Rad Laboratories, Inc. Viral Vector Purification Product

Table 59. Bio-Rad Laboratories, Inc. Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 60. Bio-Rad Laboratories, Inc. Recent Development

Table 61. Sirion-Biotech GmbH Company Details

Table 62. Sirion-Biotech GmbH Business Overview

Table 63. Sirion-Biotech GmbH Viral Vector Purification Product

Table 64. Sirion-Biotech GmbH Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 65. Sirion-Biotech GmbH Recent Development

Table 66. Merck KGaA Company Details

Table 67. Merck KGaA Business Overview

Table 68. Merck KGaA Viral Vector Purification Product

Table 69. Merck KGaA Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 70. Merck KGaA Recent Development

Table 71. FUJIFILM Diosynth Biotechnologies Company Details

Table 72. FUJIFILM Diosynth Biotechnologies Business Overview

Table 73. FUJIFILM Diosynth Biotechnologies Viral Vector Purification Product

Table 74. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 75. FUJIFILM Diosynth Biotechnologies Recent Development

Table 76. Batavia Biosciences B.V. Company Details

Table 77. Batavia Biosciences B.V. Business Overview

Table 78. Batavia Biosciences B.V. Viral Vector Purification Product

Table 79. Batavia Biosciences B.V. Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 80. Batavia Biosciences B.V. Recent Development

Table 81. Agilent Technologies, Inc. Company Details

Table 82. Agilent Technologies, Inc. Business Overview

Table 83. Agilent Technologies, Inc. Viral Vector Purification Product

Table 84. Agilent Technologies, Inc. Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 85. Agilent Technologies, Inc. Recent Development

Table 86. Addgene Company Details

Table 87. Addgene Business Overview

Table 88. Addgene Viral Vector Purification Product

Table 89. Addgene Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 90. Addgene Recent Development

Table 91. IDT Biologika GmbH Company Details

Table 92. IDT Biologika GmbH Business Overview

Table 93. IDT Biologika GmbH Viral Vector Purification Product

Table 94. IDT Biologika GmbH Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 95. IDT Biologika GmbH Recent Development

Table 96. ProBioGen AG Company Details

Table 97. ProBioGen AG Business Overview

Table 98. ProBioGen AG Viral Vector Purification Product

Table 99. ProBioGen AG Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 100. ProBioGen AG Recent Development

Table 101. Takara Bio Inc. Company Details

Table 102. Takara Bio Inc. Business Overview

Table 103. Takara Bio Inc. Viral Vector Purification Product

Table 104. Takara Bio Inc. Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 105. Takara Bio Inc. Recent Development

Table 106. Thermo Fisher Scientific Inc., Company Details

Table 107. Thermo Fisher Scientific Inc., Business Overview

Table 108. Thermo Fisher Scientific Inc., Viral Vector Purification Product

Table 109. Thermo Fisher Scientific Inc., Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 110. Thermo Fisher Scientific Inc., Recent Development

Table 111. Waisman Biomanufacturing Company Details

Table 112. Waisman Biomanufacturing Business Overview

Table 113. Waisman Biomanufacturing Viral Vector Purification Product

Table 114. Waisman Biomanufacturing Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 115. Waisman Biomanufacturing Recent Development

Table 116. Creative Biogene Company Details

Table 117. Creative Biogene Business Overview

Table 118. Creative Biogene Viral Vector Purification Product

Table 119. Creative Biogene Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 120. Creative Biogene Recent Development

Table 121. Aldevron Company Details

Table 122. Aldevron Business Overview

Table 123. Aldevron Viral Vector Purification Product

Table 124. Aldevron Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 125. Aldevron Recent Development

Table 126. BioVision Inc. Company Details

Table 127. BioVision Inc. Business Overview

Table 128. BioVision Inc. Viral Vector Purification Product

Table 129. BioVision Inc. Revenue in Viral Vector Purification Business (2020-2025) & (US$ Million)

Table 130. BioVision Inc. Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. Authors List of This Report

List of Figures

Figure 1. Viral Vector Purification Picture

Figure 2. Global Viral Vector Purification Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Viral Vector Purification Market Share by Type: 2024 VS 2031

Figure 4. In Vivo Features

Figure 5. In Vitro Features

Figure 6. Global Viral Vector Purification Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Viral Vector Purification Market Share by Application: 2024 VS 2031

Figure 8. Gene Therapy Case Studies

Figure 9. Cell Therapy Case Studies

Figure 10. Vaccinology Case Studies

Figure 11. Viral Vector Purification Report Years Considered

Figure 12. Global Viral Vector Purification Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Viral Vector Purification Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Viral Vector Purification Market Share by Region: 2024 VS 2031

Figure 15. Global Viral Vector Purification Market Share by Players in 2024

Figure 16. Global Top Viral Vector Purification Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Purification as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Viral Vector Purification Revenue in 2024

Figure 18. North America Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Viral Vector Purification Market Share by Country (2020-2031)

Figure 20. United States Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Viral Vector Purification Market Share by Country (2020-2031)

Figure 24. Germany Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Viral Vector Purification Market Share by Region (2020-2031)

Figure 32. China Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Viral Vector Purification Market Share by Country (2020-2031)

Figure 40. Mexico Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Viral Vector Purification Market Share by Country (2020-2031)

Figure 44. Turkey Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Viral Vector Purification Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Applied Biological Materials Inc. Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 48. Creative Biolabs Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 49. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 50. Sirion-Biotech GmbH Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 51. Merck KGaA Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 52. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 53. Batavia Biosciences B.V. Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 54. Agilent Technologies, Inc. Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 55. Addgene Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 56. IDT Biologika GmbH Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 57. ProBioGen AG Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 58. Takara Bio Inc. Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 59. Thermo Fisher Scientific Inc., Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 60. Waisman Biomanufacturing Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 61. Creative Biogene Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 62. Aldevron Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 63. BioVision Inc. Revenue Growth Rate in Viral Vector Purification Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Viral Vector Manufacturing Market Research Report 2024

Global Viral Vector Based Gene Therapy Drugs Market Research Report 2024

Global Viral Vector Development and Manufacturing Services Market Research Report 2025

Global Viral Vectors Gene Therapy Market Research Report 2025

Global Research Grade Viral Vector Packaging Service Market Research Report 2025

Viral Vector Packaging Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vector Based Gene Therapy Market Research Report 2025

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2025

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Viral Vector and Plasmid DNA Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Clearance Service Market Insights Forecast to 2030

Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global AAV Purification Kit Market Research Report 2024

Global Adenovirus Purification Kit Market Research Report 2024

Viral Vector and Plasmid DNA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Viral Vector Production Research use Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vectors Non Viral Vectors and Gene Therapy Manufacturing Market Research Report 2024

Global Viral DNA Purification Kit Market Insights Forecast to 2030

Global Virus Precipitation Solution Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions